AMYT logo

Amryt Pharma (AMYT) Depreciation And Amortization

Annual D&A

$50.74 M
+$6.28 M+14.12%

December 31, 2021

Summary

Performance

1-Year Change

+14.12%

3-Year Change

+13726.7%

5-Year Change

+16232.15%

15-Year Change

+16232.15%

AMYT Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$50.74 M
AMYT annual depreciation & amortization is currently at an all-time high

3-Year Low

$50.74 M
AMYT annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
AMYT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
AMYT next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$244.18 M
AMYT annual total expenses is $244.18 million

Annual Operating Expenses

$138.06 M
AMYT annual total operating expenses is $138.06 million

Annual Cost Of Goods Sold

$106.12 M
AMYT annual cost of goods sold is $106.12 million

Annual Interest Expense

$23.46 M
AMYT annual interest expense is $23.46 million

Quarterly D&A

$16.98 M
+$2.11 M+14.21%

September 30, 2022

Summary

Performance

3-Month Change

+14.21%

1-Year Change

+29.02%

3-Year Change

+14047.5%

5-Year Change

-

AMYT Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$16.98 M
AMYT quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$14.83 M
AMYT quarterly depreciation & amortization is currently +14.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AMYT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AMYT next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$71.59 M
AMYT quarterly total expenses is $71.59 million

Quarterly Operating Expenses

$37.88 M
AMYT quarterly total operating expenses is $37.88 million

Quarterly Cost Of Goods Sold

$33.70 M
AMYT quarterly cost of goods sold is $33.70 million

Quarterly Interest Expense

$6.36 M
AMYT quarterly interest expense is $6.36 million

TTM D&A

$62.18 M
+$3.82 M+6.54%

September 30, 2022

Summary

Performance

3-Month Change

+6.54%

1-Year Change

+34.03%

3-Year Change

+406.29%

5-Year Change

+406.29%

AMYT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$62.18 M
AMYT TTM depreciation & amortization is currently at an all-time high

3-Year Low

$50.74 M
AMYT TTM depreciation & amortization is currently +22.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AMYT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AMYT next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$244.18 M
AMYT annual total expenses is $244.18 million

Annual Operating Expenses

$138.06 M
AMYT annual total operating expenses is $138.06 million

TTM Cost Of Goods Sold

$127.03 M
AMYT TTM cost of goods sold is $127.03 million

TTM Interest Expense

$27.54 M
AMYT TTM interest expense is $27.54 million

AMYT Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.1%+29.0%+34.0%
3 y3 years+10000.0%+10000.0%+406.3%
5 y5 years+10000.0%-+406.3%

AMYT Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-12.6%at high-18.4%
5 y5-yearat high-75.8%at high-37.8%at high-80.2%
alltimeall timeat high-100.0%at high-99.5%at high-99.9%

Amryt Pharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2022
-
$16.98 M(+14.2%)
$62.18 M(+6.5%)
Jun 2022
-
$14.87 M(+0.2%)
$58.36 M(+7.0%)
Mar 2022
-
$14.83 M(-4.4%)
$54.52 M(+7.4%)
Dec 2021
$50.74 M(+14.1%)
$15.51 M(+17.8%)
$50.74 M(+9.4%)
Sep 2021
-
$13.16 M(+19.4%)
$46.39 M(+5.9%)
Jun 2021
-
$11.02 M(-0.3%)
$43.80 M(-1.1%)
Mar 2021
-
$11.06 M(-0.8%)
$44.28 M(-0.4%)
Dec 2020
$44.47 M(+262.1%)
$11.15 M(+5.5%)
$44.47 M(-1.5%)
Sep 2020
-
$10.57 M(-8.2%)
$45.15 M(+30.1%)
Jun 2020
-
$11.51 M(+2.4%)
$34.70 M(+48.1%)
Mar 2020
-
$11.24 M(-5.0%)
$23.43 M(+90.8%)
Dec 2019
$12.28 M
$11.83 M(+9761.7%)
$12.28 M(+2647.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
$120.00 K(-49.2%)
$447.00 K(+36.7%)
Jun 2019
-
$236.00 K(+159.3%)
$327.00 K(+259.3%)
Mar 2019
-
$91.00 K
$91.00 K
Dec 2018
$367.00 K(+18.1%)
-
-
Dec 2017
$310.70 K(+52.3%)
-
-
Dec 2016
$204.00 K(>+9900.0%)
-
-
Dec 2015
$0.00(-100.0%)
-
-
Mar 2015
$5400.00(-10.0%)
-
-
Mar 2014
$6000.00(+50.0%)
-
-
Mar 2013
$4000.00(+150.0%)
-
-
Mar 2012
$1600.00(-98.7%)
-
-
Dec 2007
$124.90 K
-
-

FAQ

  • What is Amryt Pharma annual depreciation & amortization?
  • What is the all time high annual D&A for Amryt Pharma?
  • What is Amryt Pharma annual D&A year-on-year change?
  • What is Amryt Pharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Amryt Pharma?
  • What is Amryt Pharma quarterly D&A year-on-year change?
  • What is Amryt Pharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for Amryt Pharma?
  • What is Amryt Pharma TTM D&A year-on-year change?

What is Amryt Pharma annual depreciation & amortization?

The current annual D&A of AMYT is $50.74 M

What is the all time high annual D&A for Amryt Pharma?

Amryt Pharma all-time high annual depreciation & amortization is $50.74 M

What is Amryt Pharma annual D&A year-on-year change?

Over the past year, AMYT annual depreciation & amortization has changed by +$6.28 M (+14.12%)

What is Amryt Pharma quarterly depreciation & amortization?

The current quarterly D&A of AMYT is $16.98 M

What is the all time high quarterly D&A for Amryt Pharma?

Amryt Pharma all-time high quarterly depreciation & amortization is $16.98 M

What is Amryt Pharma quarterly D&A year-on-year change?

Over the past year, AMYT quarterly depreciation & amortization has changed by +$3.82 M (+29.02%)

What is Amryt Pharma TTM depreciation & amortization?

The current TTM D&A of AMYT is $62.18 M

What is the all time high TTM D&A for Amryt Pharma?

Amryt Pharma all-time high TTM depreciation & amortization is $62.18 M

What is Amryt Pharma TTM D&A year-on-year change?

Over the past year, AMYT TTM depreciation & amortization has changed by +$15.79 M (+34.03%)